Evidence map›Paper›PMID 32914330›Full record

ReviewReviews in endocrine & metabolic disorders2020

Multidisciplinary management of acromegaly: A consensus.

Andrea Giustina, Garni Barkhoudarian, Albert Beckers, Anat Ben-Shlomo, Nienke Biermasz, Beverly Biller, Cesar Boguszewski, Marek Bolanowski, Jens Bollerslev, Vivien Bonert and 38 more

Abstract readConsensus StatementReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 196 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
196citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

196 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Clinical characteristics associated with somaticFrontiers in endocrinology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Uterine fibroids in women diagnosed with acromegaly: a systematic review.Reviews in endocrine & metabolic disorders · 2024
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Article
  17. Article
  18. Can acromegaly be controlled in all cases?Journal of neuroendocrinology · 2026
    Review
  19. Article
  20. Article

136 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Andrea GiustinaInstitute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University, IRCCS San Raffaele Hospital, Ospedale San Raffaele, Via Olgettina, 58, 20132, Milan, Italy. giustina.andrea@hsr.it.
Garni BarkhoudarianPacific Pituitary Disorders Center, Pacific Neuroscience Institute, Santa Monica, CA, USA.
Albert BeckersDepartment of Endocrinology, University of Liège, Liège, Belgium.
Anat Ben-ShlomoPituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Nienke BiermaszDivision of Endocrinology and Center for Endocrine Tumors, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Beverly BillerNeuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Cesar BoguszewskiSEMPR, Endocrine Division, Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil.
Marek BolanowskiDepartment of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland.
Jens BollerslevSection of Specialized Endocrinology, Department of Endocrinology, University of Oslo, Oslo, Norway.
Vivien BonertPituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Marcello D BronsteinNeuroendocrine Unit, Division of Endocrinology and Metabolism, Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil.
Michael BuchfelderDepartment of Neurosurgery, University Hospital Erlangen, Erlangen, Germany.
Felipe CasanuevaDivision of Endocrinology, Santiago de Compostela University and Ciber OBN, Santiago de Compostela, Spain.
Philippe ChansonCentre de Référence des Maladies Rares de l'Hypophyse and Université Paris-Saclay, Univ. Paris-Sud, Inserm, Signalisation Hormonale, Physiopathologie Endocrinienne et Métabolique, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre, Paris, France.
David ClemmonsDepartment of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Maria FleseriuDepartments of Medicine and Neurological Surgery, Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA.
Anna Maria FormentiInstitute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University, IRCCS San Raffaele Hospital, Ospedale San Raffaele, Via Olgettina, 58, 20132, Milan, Italy.
Pamela FredaDepartment of Medicine, Columbia University, Vagelos College of Physicians and Surgeons, New York, NY, USA.
Monica GadelhaNeuroendocrinology Research Center/Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Eliza GeerMultidisciplinary Pituitary and Skull Base Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Mark GurnellMetabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK.
Anthony P HeaneyDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Ken K Y HoThe Garvan Institute of Medical Research, St. Vincent's Hospital, University of New South Wales, Sydney, Australia.
Adriana G IoachimescuDepartment of Neurosurgery and Medicine, Division of Endocrinology, Metabolism and Lipids, Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA.
Steven LambertsErasmus Medical Center, Rotterdam, The Netherlands.
Edward LawsPituitary/Neuroendocrine Center, Brigham & Women's Hospital, Boston, MA, USA.
Marco LosaDepartment of Neurosurgery, San Raffaele University Health Institute Milan, Milan, Italy.
Pietro MaffeiDepartment of Medicine, Padua University Hospital, Padua, Italy.
Adam MamelakPituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Moises MercadoMedical Research Unit in Endcrine Diseases, Hospital de Especialidades, Centro Médico Nacional, Siglo XXI, IMSS, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Mark MolitchDivision of Endocrinology, Metabolism & Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Pietro MortiniDepartment of Neurosurgery, San Raffaele University Health Institute Milan, Milan, Italy.
Alberto M PereiraDivision of Endocrinology and Center for Endocrine Tumors, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Stephan PetersennENDOC Center for Endocrine Tumors, Hamburg, Germany.
Kalmon PostDepartment of Neurosurgery, Medicine, Mount Sinai Health System, New York, NY, USA.
Manuel Puig-DomingoGermans Trias i Pujol Research Institute, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.
Roberto SalvatoriDivision of Endocrinology, Diabetes, and Metabolism and Pituitary Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Susan L SamsonDepartments of Medicine and Neurosurgery, Baylor St. Luke's Pituitary Center, Baylor College of Medicine, Houson, TX, USA.
Ilan ShimonEndocrine Institute, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.
Christian StrasburgerDepartment of Medicine for Endocrinology, Diabetes and Nutritional Medicine, Charité Universitätsmedizin, Berlin, Germany.
Brooke SwearingenDepartment of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
Peter TrainerDepartment of Endocrinology, The Christie NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Mary L VanceDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
John WassDepartment of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.
Margaret E WiermanPituitary, Adrenal and Neuroendocrine Tumor Program, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, USA.
Kevin C J YuenBarrow Pituitary Center and Neuroendocrinology Clinic, Barrow Neurological Institute, University of Arizona College of Medicine, Creighton School of Medicine, Phoenix, AZ, USA.
Maria Chiara ZatelliSection of Endocrinology & Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Shlomo MelmedPituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
New Approaches to the Evaluation and Treatment of AcromegalyR01DK110771 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FREDA, PAMELA U · 2017 to 2020
$2.3M
NCI NIH HHS P30 CA008748NIDDK NIH HHS R01 DK110771
6 · The paper itself

Abstract

The 13th Acromegaly Consensus Conference was held in November 2019 in Fort Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and neurosurgeons who considered optimal approaches for multidisciplinary acromegaly management. Focused discussions reviewed techniques, results, and side effects of surgery, radiotherapy, and medical therapy, and how advances in technology and novel techniques have changed the way these modalities are used alone or in combination. Effects of treatment on patient outcomes were considered, along with strategies for optimizing and personalizing therapeutic approaches. Expert consensus recommendations emphasize how best to implement available treatment options as part of a multidisciplinary approach at Pituitary Tumor Centers of Excellence.

Indexed as

ConsensusNeurosurgical ProceduresPatient Care TeamRadiotherapyAcromegalyDopamine AgonistsHumansReceptors, SomatotropinSomatostatinDopamine AgonistsReceptors, SomatotropinSomatostatinAcromegalyConsensusMedical therapyMultidisciplinary managementPituitary tumor centers of excellenceRadiotherapySurgery

Identifiers

PMID32914330
PMCPMC7942783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.